CDKN2A and lung cancer: Although there may be some possible limitations in our study, such as the small number of patients and lack of follow-up data for survival analysis, it contributes to the literature by providing information about the prevalence of HPV, the distribution of HPV types, and its relationship with p16 in lung cancer patients from the Mediterranean region of Turkey.